Idéal Investisseur
Français English
CAC 40 : Market closed
8 218,24 pts
-0.32%


Last updated : 05/06/2026 - 17h29
🏠 Home   ➤    Stock news

EssilorLuxottica Stock: Confirmation of a Rebound After a 18% Drop in Spring

The Franco-Italian optical giant continues its recovery in mid-session, within a slightly positive CAC 40. The stock has moved back above a short-term technical benchmark and benefits from a coverage revision by a broker. However, the underlying bearish trend remains significant, following a challenging spring.


EssilorLuxottica Stock: Confirmation of a Rebound After a 18% Drop in Spring

Rothschild & Co Redburn Confirms Buy Rating but Lowers Target on EssilorLuxottica

The stock is among the top gainers in the CAC 40 during the session, as the index rises by 0.19%. Rothschild & Co Redburn has reduced its price target on EssilorLuxottica from €310 to €260, while maintaining its buy recommendation, according to a revision dated June 3. Based on the current price of €178.75, the new target still offers a theoretical potential of about 45%. Beyond this coverage adjustment, the recent corporate agenda remains busy: on June 1, the group noted a capital increase related to the payment of the 2025 dividend in shares, with 957,954 new shares issued.

The Stock Moves Above the MM20 but Remains Significantly Detached from Its MM200

Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
Before 9 AM every morning Euronext data AI-powered analysis

At €178.75, the price is now above the 20-day moving average (€172.91), with a gap of 3.4% indicating a short-term recovery. However, the MM50 (€185.06) remains above the price, at a 3.4% distance, and the MM200 (€249.52) is still 28% above, a legacy of a nearly 18.5% drop over three months and more than 26% over a year. The RSI at 49 indicates a dynamic that has returned to neutral, after hitting multi-year lows around €162.50 in mid-May. The technical support identified at €165.45 did not hold during the most recent trough (around €162.50), while the resistance at €191.80 remains the next threshold to cross for a more lasting reversal.



Sector Luxe Fournitures Médicales


Assurance vie

Context

Period
  • Period: 1T2026
Key reported figures
  • Revenue: 7127M€
Guidance from the release
  • Avec ce troisième trimestre consécutif de croissance à deux chiffres...
  • Chiffre d'affaires en hausse de +10,8 % au T1 2026.
Risks mentioned
  • Environnement incertain qui pourrait affecter la dynamique.
  • Pressions dans le secteur de la santé visuelle.
Opportunities identified
  • Lancement réussi des nouveaux modèles optiques Ray-Ban Meta.
  • Expansion du réseau de distribution avec l'investissement en Thaïlande.

The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.

Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.

Advertisement
Every morning
Technical market signals,
before the opening bell.
CAC 40 · SBF 120 · Signals · Analysts
🤖
Today's edition — pre-market
CAC 40
7 702
-0,87%
SBF 120
5 827
-0,87%
📈 Bullish signals
+5,2%
+1,8%
+0,9%
📉 Bearish signals
-14%
-5,7%
🔄 Analyst opinions
▲ 35 €
▼ 80 €
Sign up to see everything →
Before 9 AM every morning
Euronext data
AI-powered analysis





BOURSE · Chaque matin
La synthèse bourse,
avant l'ouverture.
Notre moteur analyse chaque nuit le CAC 40 et le SBF 120. Ce qui mérite attention remonte directement dans votre boîte mail. Gratuit.
Avant 9h00 1000+ inscrits 100% gratuit